About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Pneumonia Therapeutics Market Size, Growth, Forecast to 2031
Pneumonia Therapeutics Market

Pneumonia Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Vaccines, Therapeutic Drugs, Antibacterial Drugs, Macrolide, Quinolones, Antiviral Drugs, Oseltamivir phosphate, Zanamivir, Antifungal Drugs, Clotrimazole, Econazole), By Type (Drugs, Preventive Vaccines, Oxygen Therapy, Route of Administration, Oral, Parenteral, Others), By Age Group (Pediatric, Adult, Geriatric), By Mode of Infection (Hospital-acquired pneumonia (HAP), Community-acquired pneumonia (CAP), Ventilator-associated pneumonia (VAP)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI1189DR
Last Updated : December 07, 2022
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Pneumonia Therapeutics Market Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Vaccines
        1. By Value
      3. Therapeutic Drugs
        1. By Value
      4. Antibacterial Drugs
        1. By Value
      5. Macrolide
        1. By Value
      6. Quinolones
        1. By Value
      7. Antiviral Drugs
        1. By Value
      8. Oseltamivir phosphate
        1. By Value
      9. Zanamivir
        1. By Value
      10. Antifungal Drugs
        1. By Value
      11. Clotrimazole
        1. By Value
      12. Econazole
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Drugs
        1. By Value
      3. Preventive Vaccines
        1. By Value
      4. Oxygen Therapy
        1. By Value
      5. Route of Administration
        1. By Value
      6. Oral
        1. By Value
      7. Parenteral
        1. By Value
      8. Others
        1. By Value
    4. By Age Group
      1. Introduction
        1. Age Group By Value
      2. Pediatric
        1. By Value
      3. Adult
        1. By Value
      4. Geriatric
        1. By Value
    5. By Mode of Infection
      1. Introduction
        1. Mode of Infection By Value
      2. Hospital-acquired pneumonia (HAP)
        1. By Value
      3. Community-acquired pneumonia (CAP)
        1. By Value
      4. Ventilator-associated pneumonia (VAP)
        1. By Value
    6. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospital Pharmacies
        1. By Value
      3. Retail Pharmacies
        1. By Value
      4. Online Pharmacies
        1. By Value
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Vaccines
        1. By Value
      3. Therapeutic Drugs
        1. By Value
      4. Antibacterial Drugs
        1. By Value
      5. Macrolide
        1. By Value
      6. Quinolones
        1. By Value
      7. Antiviral Drugs
        1. By Value
      8. Oseltamivir phosphate
        1. By Value
      9. Zanamivir
        1. By Value
      10. Antifungal Drugs
        1. By Value
      11. Clotrimazole
        1. By Value
      12. Econazole
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Drugs
        1. By Value
      3. Preventive Vaccines
        1. By Value
      4. Oxygen Therapy
        1. By Value
      5. Route of Administration
        1. By Value
      6. Oral
        1. By Value
      7. Parenteral
        1. By Value
      8. Others
        1. By Value
    4. By Age Group
      1. Introduction
        1. Age Group By Value
      2. Pediatric
        1. By Value
      3. Adult
        1. By Value
      4. Geriatric
        1. By Value
    5. By Mode of Infection
      1. Introduction
        1. Mode of Infection By Value
      2. Hospital-acquired pneumonia (HAP)
        1. By Value
      3. Community-acquired pneumonia (CAP)
        1. By Value
      4. Ventilator-associated pneumonia (VAP)
        1. By Value
    6. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospital Pharmacies
        1. By Value
      3. Retail Pharmacies
        1. By Value
      4. Online Pharmacies
        1. By Value
    7. U.S.
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Vaccines
          1. By Value
        3. Therapeutic Drugs
          1. By Value
        4. Antibacterial Drugs
          1. By Value
        5. Macrolide
          1. By Value
        6. Quinolones
          1. By Value
        7. Antiviral Drugs
          1. By Value
        8. Oseltamivir phosphate
          1. By Value
        9. Zanamivir
          1. By Value
        10. Antifungal Drugs
          1. By Value
        11. Clotrimazole
          1. By Value
        12. Econazole
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Drugs
          1. By Value
        3. Preventive Vaccines
          1. By Value
        4. Oxygen Therapy
          1. By Value
        5. Route of Administration
          1. By Value
        6. Oral
          1. By Value
        7. Parenteral
          1. By Value
        8. Others
          1. By Value
      3. By Age Group
        1. Introduction
          1. Age Group By Value
        2. Pediatric
          1. By Value
        3. Adult
          1. By Value
        4. Geriatric
          1. By Value
      4. By Mode of Infection
        1. Introduction
          1. Mode of Infection By Value
        2. Hospital-acquired pneumonia (HAP)
          1. By Value
        3. Community-acquired pneumonia (CAP)
          1. By Value
        4. Ventilator-associated pneumonia (VAP)
          1. By Value
      5. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospital Pharmacies
          1. By Value
        3. Retail Pharmacies
          1. By Value
        4. Online Pharmacies
          1. By Value
    8. Canada
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Vaccines
        1. By Value
      3. Therapeutic Drugs
        1. By Value
      4. Antibacterial Drugs
        1. By Value
      5. Macrolide
        1. By Value
      6. Quinolones
        1. By Value
      7. Antiviral Drugs
        1. By Value
      8. Oseltamivir phosphate
        1. By Value
      9. Zanamivir
        1. By Value
      10. Antifungal Drugs
        1. By Value
      11. Clotrimazole
        1. By Value
      12. Econazole
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Drugs
        1. By Value
      3. Preventive Vaccines
        1. By Value
      4. Oxygen Therapy
        1. By Value
      5. Route of Administration
        1. By Value
      6. Oral
        1. By Value
      7. Parenteral
        1. By Value
      8. Others
        1. By Value
    4. By Age Group
      1. Introduction
        1. Age Group By Value
      2. Pediatric
        1. By Value
      3. Adult
        1. By Value
      4. Geriatric
        1. By Value
    5. By Mode of Infection
      1. Introduction
        1. Mode of Infection By Value
      2. Hospital-acquired pneumonia (HAP)
        1. By Value
      3. Community-acquired pneumonia (CAP)
        1. By Value
      4. Ventilator-associated pneumonia (VAP)
        1. By Value
    6. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospital Pharmacies
        1. By Value
      3. Retail Pharmacies
        1. By Value
      4. Online Pharmacies
        1. By Value
    7. U.K.
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Vaccines
          1. By Value
        3. Therapeutic Drugs
          1. By Value
        4. Antibacterial Drugs
          1. By Value
        5. Macrolide
          1. By Value
        6. Quinolones
          1. By Value
        7. Antiviral Drugs
          1. By Value
        8. Oseltamivir phosphate
          1. By Value
        9. Zanamivir
          1. By Value
        10. Antifungal Drugs
          1. By Value
        11. Clotrimazole
          1. By Value
        12. Econazole
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Drugs
          1. By Value
        3. Preventive Vaccines
          1. By Value
        4. Oxygen Therapy
          1. By Value
        5. Route of Administration
          1. By Value
        6. Oral
          1. By Value
        7. Parenteral
          1. By Value
        8. Others
          1. By Value
      3. By Age Group
        1. Introduction
          1. Age Group By Value
        2. Pediatric
          1. By Value
        3. Adult
          1. By Value
        4. Geriatric
          1. By Value
      4. By Mode of Infection
        1. Introduction
          1. Mode of Infection By Value
        2. Hospital-acquired pneumonia (HAP)
          1. By Value
        3. Community-acquired pneumonia (CAP)
          1. By Value
        4. Ventilator-associated pneumonia (VAP)
          1. By Value
      5. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospital Pharmacies
          1. By Value
        3. Retail Pharmacies
          1. By Value
        4. Online Pharmacies
          1. By Value
    8. Germany
    9. France
    10. Spain
    11. Italy
    12. Russia
    13. Nordic
    14. Benelux
    15. Rest of Europe
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Vaccines
        1. By Value
      3. Therapeutic Drugs
        1. By Value
      4. Antibacterial Drugs
        1. By Value
      5. Macrolide
        1. By Value
      6. Quinolones
        1. By Value
      7. Antiviral Drugs
        1. By Value
      8. Oseltamivir phosphate
        1. By Value
      9. Zanamivir
        1. By Value
      10. Antifungal Drugs
        1. By Value
      11. Clotrimazole
        1. By Value
      12. Econazole
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Drugs
        1. By Value
      3. Preventive Vaccines
        1. By Value
      4. Oxygen Therapy
        1. By Value
      5. Route of Administration
        1. By Value
      6. Oral
        1. By Value
      7. Parenteral
        1. By Value
      8. Others
        1. By Value
    4. By Age Group
      1. Introduction
        1. Age Group By Value
      2. Pediatric
        1. By Value
      3. Adult
        1. By Value
      4. Geriatric
        1. By Value
    5. By Mode of Infection
      1. Introduction
        1. Mode of Infection By Value
      2. Hospital-acquired pneumonia (HAP)
        1. By Value
      3. Community-acquired pneumonia (CAP)
        1. By Value
      4. Ventilator-associated pneumonia (VAP)
        1. By Value
    6. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospital Pharmacies
        1. By Value
      3. Retail Pharmacies
        1. By Value
      4. Online Pharmacies
        1. By Value
    7. China
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Vaccines
          1. By Value
        3. Therapeutic Drugs
          1. By Value
        4. Antibacterial Drugs
          1. By Value
        5. Macrolide
          1. By Value
        6. Quinolones
          1. By Value
        7. Antiviral Drugs
          1. By Value
        8. Oseltamivir phosphate
          1. By Value
        9. Zanamivir
          1. By Value
        10. Antifungal Drugs
          1. By Value
        11. Clotrimazole
          1. By Value
        12. Econazole
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Drugs
          1. By Value
        3. Preventive Vaccines
          1. By Value
        4. Oxygen Therapy
          1. By Value
        5. Route of Administration
          1. By Value
        6. Oral
          1. By Value
        7. Parenteral
          1. By Value
        8. Others
          1. By Value
      3. By Age Group
        1. Introduction
          1. Age Group By Value
        2. Pediatric
          1. By Value
        3. Adult
          1. By Value
        4. Geriatric
          1. By Value
      4. By Mode of Infection
        1. Introduction
          1. Mode of Infection By Value
        2. Hospital-acquired pneumonia (HAP)
          1. By Value
        3. Community-acquired pneumonia (CAP)
          1. By Value
        4. Ventilator-associated pneumonia (VAP)
          1. By Value
      5. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospital Pharmacies
          1. By Value
        3. Retail Pharmacies
          1. By Value
        4. Online Pharmacies
          1. By Value
    8. Korea
    9. Japan
    10. India
    11. Australia
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Vaccines
        1. By Value
      3. Therapeutic Drugs
        1. By Value
      4. Antibacterial Drugs
        1. By Value
      5. Macrolide
        1. By Value
      6. Quinolones
        1. By Value
      7. Antiviral Drugs
        1. By Value
      8. Oseltamivir phosphate
        1. By Value
      9. Zanamivir
        1. By Value
      10. Antifungal Drugs
        1. By Value
      11. Clotrimazole
        1. By Value
      12. Econazole
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Drugs
        1. By Value
      3. Preventive Vaccines
        1. By Value
      4. Oxygen Therapy
        1. By Value
      5. Route of Administration
        1. By Value
      6. Oral
        1. By Value
      7. Parenteral
        1. By Value
      8. Others
        1. By Value
    4. By Age Group
      1. Introduction
        1. Age Group By Value
      2. Pediatric
        1. By Value
      3. Adult
        1. By Value
      4. Geriatric
        1. By Value
    5. By Mode of Infection
      1. Introduction
        1. Mode of Infection By Value
      2. Hospital-acquired pneumonia (HAP)
        1. By Value
      3. Community-acquired pneumonia (CAP)
        1. By Value
      4. Ventilator-associated pneumonia (VAP)
        1. By Value
    6. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospital Pharmacies
        1. By Value
      3. Retail Pharmacies
        1. By Value
      4. Online Pharmacies
        1. By Value
    7. UAE
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Vaccines
          1. By Value
        3. Therapeutic Drugs
          1. By Value
        4. Antibacterial Drugs
          1. By Value
        5. Macrolide
          1. By Value
        6. Quinolones
          1. By Value
        7. Antiviral Drugs
          1. By Value
        8. Oseltamivir phosphate
          1. By Value
        9. Zanamivir
          1. By Value
        10. Antifungal Drugs
          1. By Value
        11. Clotrimazole
          1. By Value
        12. Econazole
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Drugs
          1. By Value
        3. Preventive Vaccines
          1. By Value
        4. Oxygen Therapy
          1. By Value
        5. Route of Administration
          1. By Value
        6. Oral
          1. By Value
        7. Parenteral
          1. By Value
        8. Others
          1. By Value
      3. By Age Group
        1. Introduction
          1. Age Group By Value
        2. Pediatric
          1. By Value
        3. Adult
          1. By Value
        4. Geriatric
          1. By Value
      4. By Mode of Infection
        1. Introduction
          1. Mode of Infection By Value
        2. Hospital-acquired pneumonia (HAP)
          1. By Value
        3. Community-acquired pneumonia (CAP)
          1. By Value
        4. Ventilator-associated pneumonia (VAP)
          1. By Value
      5. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospital Pharmacies
          1. By Value
        3. Retail Pharmacies
          1. By Value
        4. Online Pharmacies
          1. By Value
    8. Turkey
    9. Saudi Arabia
    10. South Africa
    11. Egypt
    12. Nigeria
    13. Rest of MEA
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. Vaccines
        1. By Value
      3. Therapeutic Drugs
        1. By Value
      4. Antibacterial Drugs
        1. By Value
      5. Macrolide
        1. By Value
      6. Quinolones
        1. By Value
      7. Antiviral Drugs
        1. By Value
      8. Oseltamivir phosphate
        1. By Value
      9. Zanamivir
        1. By Value
      10. Antifungal Drugs
        1. By Value
      11. Clotrimazole
        1. By Value
      12. Econazole
        1. By Value
    3. By Type
      1. Introduction
        1. Type By Value
      2. Drugs
        1. By Value
      3. Preventive Vaccines
        1. By Value
      4. Oxygen Therapy
        1. By Value
      5. Route of Administration
        1. By Value
      6. Oral
        1. By Value
      7. Parenteral
        1. By Value
      8. Others
        1. By Value
    4. By Age Group
      1. Introduction
        1. Age Group By Value
      2. Pediatric
        1. By Value
      3. Adult
        1. By Value
      4. Geriatric
        1. By Value
    5. By Mode of Infection
      1. Introduction
        1. Mode of Infection By Value
      2. Hospital-acquired pneumonia (HAP)
        1. By Value
      3. Community-acquired pneumonia (CAP)
        1. By Value
      4. Ventilator-associated pneumonia (VAP)
        1. By Value
    6. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospital Pharmacies
        1. By Value
      3. Retail Pharmacies
        1. By Value
      4. Online Pharmacies
        1. By Value
    7. Brazil
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. Vaccines
          1. By Value
        3. Therapeutic Drugs
          1. By Value
        4. Antibacterial Drugs
          1. By Value
        5. Macrolide
          1. By Value
        6. Quinolones
          1. By Value
        7. Antiviral Drugs
          1. By Value
        8. Oseltamivir phosphate
          1. By Value
        9. Zanamivir
          1. By Value
        10. Antifungal Drugs
          1. By Value
        11. Clotrimazole
          1. By Value
        12. Econazole
          1. By Value
      2. By Type
        1. Introduction
          1. Type By Value
        2. Drugs
          1. By Value
        3. Preventive Vaccines
          1. By Value
        4. Oxygen Therapy
          1. By Value
        5. Route of Administration
          1. By Value
        6. Oral
          1. By Value
        7. Parenteral
          1. By Value
        8. Others
          1. By Value
      3. By Age Group
        1. Introduction
          1. Age Group By Value
        2. Pediatric
          1. By Value
        3. Adult
          1. By Value
        4. Geriatric
          1. By Value
      4. By Mode of Infection
        1. Introduction
          1. Mode of Infection By Value
        2. Hospital-acquired pneumonia (HAP)
          1. By Value
        3. Community-acquired pneumonia (CAP)
          1. By Value
        4. Ventilator-associated pneumonia (VAP)
          1. By Value
      5. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospital Pharmacies
          1. By Value
        3. Retail Pharmacies
          1. By Value
        4. Online Pharmacies
          1. By Value
    8. Mexico
    9. Argentina
    10. Chile
    11. Colombia
    12. Rest of LATAM
    1. Pneumonia Therapeutics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Abbott Laboratories
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Allergan
    3. AstraZeneca
    4. Bayer
    5. Cipla
    6. GlaxoSmithKline Plc.
    7. Lupin Pharmaceuticals Ltd.
    8. Merck
    9. Mylan
    10. Novartis AG
    11. Pfizer, Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The global dermatological therapeutics market size was valued at USD 41.88 billion in 2023. It is estimated to reach USD 95.56 billion by 2032, growing at a CAGR of 9.6% during the forecast period (2024–2032). In recent years, people have becom
Buy Now
Global Report
Leukemia therapeutics are therapies used for treating leukemia at different levels. The earlier cancer is diagnosed and treated, the better the chance of its being cured. The game-changing technological advancements in the treatment of cancer are con
Buy Now
Global Report
Melanoma Therapeutics Market Size The global melanoma therapeutics market size was valued at USD 8.65 billion in 2023. It is projected to reach USD 19.87 billion by 2032, growing at a CAGR of 10.80% during the forecast period (2024–2032). Mela
Buy Now
Global Report
Pain Management Therapeutics Market Size The global pain management therapeutics market size was valued at USD 79.42 billion in 2023 and is projected to reach USD 115.21 billion by 2032, growing at a CAGR of 4.22% during the
Buy Now
Global Report
Peptide Therapeutics Market Size & Trends The global peptide therapeutics market size was valued at USD 45.43 billion in 2023. It is projected to reach from USD 48.11 billion in 2025 to USD 76.11 billion by 2033, growing at a CAGR
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.